康辰药业：10月29日召开董事会会议

Group 1 - The company, Kangchen Pharmaceutical, announced the convening of its 24th meeting of the fourth board of directors on October 29, 2025, to review the proposal for the third quarter report of 2025 [1] - For the year 2024, the company's revenue composition is heavily weighted towards the pharmaceutical manufacturing sector, accounting for 99.88%, while other businesses contribute only 0.12% [1] - As of the report date, Kangchen Pharmaceutical has a market capitalization of 7.6 billion yuan [1]